Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00467844 · OUTCOME

The Efficacy of GTx-024 on Total Body Lean Mass.

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. · Source last updated 2014-07-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
kg
Interval / dispersion
Full Range
Time frame
Baseline to Four Months

What was measured

Change in total body lean mass as measured by dual energy x-ray absorptiometry (DEXA)from baseline to 4 months.

Analysis population: The number of participants were those subjects in the modified intent-to-treat population (defined as subjects with at least one post baseline DEXA for LBM) who had baseline and 4 month DEXA results for LBM (observed cases).

Groups in this outcome

GTx-024 1 mg

Not reported

GTx-024 3 mg

Not reported

Placebo

Placebo

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
GTx-024 1 mg32
GTx-024 3 mg34
Placebo34

Reported measurements

Source class 1
Values in kg · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
GTx-024 1 mg1.55Not reported-2.0612.64Not reported
GTx-024 3 mg0.98Not reported-4.8411.54Not reported
Placebo0.02Not reported-5.817.46Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        -2.06
        upper Limit
        12.64
        value
        1.55
      2. group Id
        OG001
        lower Limit
        -4.84
        upper Limit
        11.54
        value
        0.98
      3. group Id
        OG002
        lower Limit
        -5.81
        upper Limit
        7.46
        value
        0.02
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    2. group Id
      OG001
      value
      34
    3. group Id
      OG002
      value
      34
    units
    Participants
description
Change in total body lean mass as measured by dual energy x-ray absorptiometry (DEXA)from baseline to 4 months.
dispersion Type
Full Range
groups
  1. id
    OG000
    title
    GTx-024 1 mg
  2. id
    OG001
    title
    GTx-024 3 mg
  3. description
    Placebo
    id
    OG002
    title
    Placebo
param Type
MEDIAN
population Description
The number of participants were those subjects in the modified intent-to-treat population (defined as subjects with at least one post baseline DEXA for LBM) who had baseline and 4 month DEXA results for LBM (observed cases).
reporting Status
POSTED
time Frame
Baseline to Four Months
title
The Efficacy of GTx-024 on Total Body Lean Mass.
type
PRIMARY
unit Of Measure
kg

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice